Cefprozil is used to treat certain infections caused by bacteria, such as bronchitis (infection of the airway tubes leading to the lungs); and infections of the skin, ears, sinuses, throat, and tonsils ,. Cefprozil is in a class of medications called cephalosporins and is an orally active beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin binding proteins, reducing peptidoglycan cross-linking and producing bactericidal activity against a range of gram positive cocci and selected gram negative organisms; it is formulated as an oral suspension or tablet, shows good gastrointestinal absorption, is primarily renally excreted, and is dosed according to infection type and renal function.
Parent: Amoxicillin/ Cefadroxil/ Cefprozil
The principal related compounds and degradation products monitored for cefprozil include the desacetyl derivative, epimerization products at the cephem stereocenter, oxidative products affecting the aminothiazole or dihydrothiazine rings, beta-lactam ring-opened hydrolysis products, and trace residual solvents or counterions; typical quality specifications used in production and pharmacopeial monographs control individual specified impurities generally at or below 0.5 percent relative to the API and limit total impurities to around 2.0 percent, with tighter limits applied to genotoxic or structurally alerting species, and analytical control is performed by validated HPLC with orthogonal confirmation by MS when needed.
No, cefprozil and amoxicillin are different antibiotics from distinct classes; cefprozil is a cephalosporin beta-lactam while amoxicillin is a penicillin beta-lactam, so they differ in spectrum, chemical structure, and sometimes susceptibility profiles, although both interfere with cell wall synthesis and there can be some cross-reactive allergy risk in a minority of penicillin-allergic patients.
Use during pregnancy should be discussed with a healthcare provider; available human data for cephalosporins have not shown clear evidence of teratogenicity, but therapy should be given only if the potential benefit justifies the potential risk, and dosing adjustments may be needed for altered renal function in pregnancy.
Cefprozil can be effective for some urinary tract infections when the causative organism is susceptible, but it has variable activity against common uropathogens such as Escherichia coli, so choice should be guided by local susceptibility patterns and urine culture results; other agents are often preferred for uncomplicated UTI.
Yes, like other broad spectrum antibiotics, cefprozil can disrupt normal bacterial flora and predispose to overgrowth of Candida species, leading to vaginal or oral yeast infections; if symptoms of a yeast infection occur, consult a clinician for appropriate diagnosis and management.
